You are using an older browser version. Please use a supported version for the best MSN experience.

Patent waiver doesn't address adequate vaccine supply question: U.S.-India Business Council

Even with a patent waiver, it will take months and maybe even years, before other countries have the technology, the raw materials and production capacity to make their own vaccines, says Nisha Biswal, president of the U.S.-India Business Council.

Recent Videos

Featured Partners

image beaconimage beaconimage beacon